SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131 | -30.7% | 9,023 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $189 | +37.0% | 9,023 | +37.9% | 0.00% | +100.0% |
| Q1 2023 | $138 | -24.2% | 6,541 | -8.5% | 0.00% | -50.0% |
| Q4 2022 | $182 | -99.9% | 7,148 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $172,000 | +29.3% | 7,148 | +3.1% | 0.00% | +100.0% |
| Q2 2022 | $133,000 | +30.4% | 6,936 | +18.0% | 0.00% | 0.0% |
| Q1 2022 | $102,000 | – | 5,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 1,350,000 | $30,024,000 | 6.69% |
| COMMODORE CAPITAL LP | 330,315 | $7,346,000 | 3.99% |
| Aisling Capital Management LP | 1,025,000 | $22,796,000 | 3.92% |
| VR Adviser, LLC | 1,115,255 | $24,803,000 | 3.65% |
| ACUTA CAPITAL PARTNERS, LLC | 465,500 | $10,353,000 | 2.82% |
| FRAZIER MANAGEMENT LLC | 1,405,045 | $31,248,000 | 2.41% |
| Avidity Partners Management LP | 3,308,000 | $73,570,000 | 2.39% |
| Altium Capital Management LP | 263,596 | $5,862,000 | 2.19% |
| Affinity Asset Advisors, LLC | 150,500 | $3,347,000 | 1.77% |
| Boxer Capital, LLC | 2,287,782 | $50,880,000 | 1.64% |